Monday, September 21, 2015

Big Price Increase for TB Drug Is Rescinded by ANDREW POLLACK


By ANDREW POLLACK

Rodelis, which acquired cycloserine and promptly raised its price more than twentyfold, returned it to the foundation that had previously owned the drug.

Published: September 22, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1QUhdnM



from WordPress http://ift.tt/1KHC2Sk
via Hadi Aboukhater
Posted by at
Labels: , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)